Praxis Precision Medicines, Inc.
PRAX
$346.84
$3.641.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 364.98% | 338.45% | 270.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 364.98% | 338.45% | 270.02% |
| Cost of Revenue | 52.65% | 75.26% | 114.73% | 146.94% | 111.04% |
| Gross Profit | -59.62% | -85.68% | -111.18% | -143.09% | -106.99% |
| SG&A Expenses | 33.05% | 4.93% | 6.98% | 28.70% | 24.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.19% | 56.29% | 81.48% | 107.75% | 82.17% |
| Operating Income | -53.36% | -62.96% | -78.71% | -104.67% | -79.00% |
| Income Before Tax | -53.62% | -65.88% | -80.80% | -102.85% | -69.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.62% | -65.88% | -80.80% | -102.85% | -69.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.62% | -65.88% | -80.80% | -102.85% | -69.54% |
| EBIT | -53.36% | -62.96% | -78.71% | -104.67% | -79.00% |
| EBITDA | -53.49% | -63.19% | -79.07% | -105.17% | -79.38% |
| EPS Basic | -24.90% | -31.18% | -25.34% | -19.64% | 32.69% |
| Normalized Basic EPS | -22.89% | -29.87% | -28.26% | -22.57% | 30.78% |
| EPS Diluted | -24.90% | -31.18% | -25.34% | -19.64% | 32.69% |
| Normalized Diluted EPS | -22.89% | -29.87% | -28.26% | -22.57% | 30.78% |
| Average Basic Shares Outstanding | 24.13% | 25.59% | 39.25% | 60.14% | 114.83% |
| Average Diluted Shares Outstanding | 24.13% | 25.59% | 39.25% | 60.14% | 114.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |